Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
fibrosis10255 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A25144 | 22140659 | Acta Biochim Pol | Cytokeratin-18 and hyaluronic acid levels predict liver fibrosis in children with non-alcoholic fatty liver disease. | 2011 | Details |
| A25154 | 22129796 | Gastroenterol Nurs | Predictors of nonalcoholic steatohepatitis in obese children. | 2012 | Details |
| A25156 | 22126450 | Scand J Gastroenterol | Low clinical relevance of the nonalcoholic fatty liver disease activity score (NAS) in predicting fibrosis progression. | 2011 | Details |
| A25157 | 22126026 | Adv Clin Chem | Iron overload in nonalcoholic steatohepatitis. | 2011 | Details |
| A25161 | 22122481 | Curr Pharm Biotechnol | Non-alcoholic steatohepatitis: new insights from OMICS studies. | 2012 | Details |
| A25165 | 22120206 | J Hepatol | Obesity, inflammation, and liver cancer. | 2011 | Details |
| A25166 | 22119618 | Dig Liver Dis | N-glycan based biomarker distinguishing non-alcoholic steatohepatitis from steatosis independently of fibrosis. | 2011 | Details |
| A25167 | 22119555 | Eur J Radiol | Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD. | 2011 | Details |
| A25169 | 22118645 | Int J Exp Pathol | Pathology of the liver in obese and diabetic ob/ob and db/db mice fed a standard or high-calorie diet. | 2011 | Details |
| A25170 | 22117531 | Aliment Pharmacol Ther | Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease. | 2011 | Details |
| A25176 | 22111040 | Diabetes Metab J | Dietary oleate has beneficial effects on every step of non-alcoholic Fatty liver disease progression in a methionine- and choline-deficient diet-fed animal model. | 2011 | Details |
| A25179 | 22110476 | Exp Diabetes Res | Diagnosis and evaluation of nonalcoholic fatty liver disease. | 2011 | Details |
| A25181 | 22110265 | World J Gastroenterol | Physical activity and nutrition attitudes in obese Hispanic children with non-alcoholic steatohepatitis. | 2011 | Details |
| A25182 | 22110053 | Gut | Genetic determinants of alcoholic liver disease. | 2011 | Details |
| A25183 | 22108808 | Obes Surg | Effect of bariatric surgery on liver fibrosis. | 2012 | Details |
| A25184 | 22108588 | Exp Cell Res | A methionine-choline-deficient diet elicits NASH in the immunodeficient mouse featuring a model for hepatic cell transplantation. | 2011 | Details |
| A25189 | 22105311 | Eur J Nutr | Cardioprotective and hepatoprotective effects of ellagitannins from European oak bark (Quercus petraea L.) extract in rats. | 2011 | Details |
| A25191 | 22103753 | Pharm Biol | Fish oil improves lipid metabolism and ameliorates inflammation in patients with metabolic syndrome: impact of nonalcoholic fatty liver disease. | 2011 | Details |
| A25192 | 22103042 | Acta Gastroenterol Belg | Lean non-alcoholic fatty liver disease (Lean-NAFLD): a major cause of cryptogenic liver disease. | 2011 | Details |
| A25197 | 22098614 | Liver Int | Growth hormone, dehydroepiandrosterone and adiponectin levels in non-alcoholic steatohepatitis: an endocrine signature for advanced fibrosis in obese patients. | 2011 | Details |
| A25198 | 22098270 | Liver Int | Impaired renal function in morbid obese patients with nonalcoholic fatty liver disease. | 2011 | Details |
| A25200 | 22097893 | Liver Int | Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease. | 2011 | Details |
| A25215 | 22087177 | Hepat Mon | Non-alcoholic fatty liver disease and correlation of serum alanin aminotransferase level with histopathologic findings. | 2011 | Details |
| A25218 | 22087126 | Hepat Mon | Noninvasive assessment of liver fibrosis with the aspartate transaminase to platelet ratio index (APRI): Usefulness in patients with chronic liver disease: APRI in chronic liver disease. | 2011 | Details |
| A25219 | 22087124 | Hepat Mon | Rosuvastatin reduces nonalcoholic fatty liver disease in patients with chronic hepatitis C treated with α-interferon and ribavirin: Rosuvastatin reduces NAFLD in HCV patients. | 2011 | Details |
| A25220 | 22083307 | Mol Cells | Time-dependent changes in lipid metabolism in mice with methionine choline deficiency-induced fatty liver disease. | 2011 | Details |
| A25225 | 22081873 | Comp Hepatol | The effect of cocoa supplementation on hepatic steatosis, reactive oxygen species and LFABP in a rat model of NASH. | 2011 | Details |
| A25226 | 22081615 | J Am Coll Nutr | Metabolic syndrome in childhood from impaired carbohydrate metabolism to nonalcoholic fatty liver disease. | 2011 | Details |
| A25237 | 22064320 | Lab Invest | A novel murine model for non-alcoholic steatohepatitis developed by combination of a high-fat diet and oxidized low-density lipoprotein. | 2011 | Details |
| A25240 | 22059109 | World J Hepatol | Role of ezetimibe in non-alcoholic fatty liver disease. | 2011 | Details |
| A25241 | 22056763 | Biochim Biophys Acta | Roles of PPARs in NAFLD: potential therapeutic targets. | 2011 | Details |
| A25243 | 22053378 | Zhonghua Gan Zang Bing Za Zhi | [The effects of curcumin derivative on experimental steatohepatitis]. | 2011 | Details |
| A25246 | 22050199 | Aliment Pharmacol Ther | Meta-analysis: pioglitazone improves liver histology and fibrosis in patients with non-alcoholic steatohepatitis. | 2011 | Details |
| A25247 | 22047200 | J Invest Surg | Type of steatosis influences microcirculation and fibrogenesis in different rat strains. | 2011 | Details |
| A25248 | 22046322 | PLoS One | Protective effects of white button mushroom (Agaricus bisporus) against hepatic steatosis in ovariectomized mice as a model of postmenopausal women. | 2011 | Details |
| A25251 | 22045426 | Dis Markers | Serum progranulin as an independent marker of liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease. | 2011 | Details |
| A25257 | 22036053 | Hum Pathol | Costaining for keratins 8/18 plus ubiquitin improves detection of hepatocyte injury in nonalcoholic fatty liver disease. | 2011 | Details |
| A25258 | 22035383 | Hepatol Res | Histopathological characteristics of non-alcoholic fatty liver disease in children: Comparison with adult cases. | 2011 | Details |
| A25262 | 22027584 | J Hepatol | Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe. | 2011 | Details |
| A25264 | 22025886 | J Magn Reson Imaging | Quantitative Assessment of Liver Fat with Magnetic Resonance Imaging and Spectroscopy. | 2011 | Details |
| A25268 | 22024080 | Hepatogastroenterology | Plasma fibrinogen-like protein 2 levels in patients with non-alcoholic fatty liver disease. | 2012 | Details |
| A25272 | 22020821 | Hepatol Int | Non-alcoholic fatty liver disease: is iron relevant? | 2011 | Details |
| A25282 | 22008893 | Am J Gastroenterol | Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma. | 2011 | Details |
| A25283 | 22008843 | Food Funct | The importance of the long-chain polyunsaturated fatty acid n-6/n-3 ratio in development of non-alcoholic fatty liver associated with obesity. | 2011 | Details |
| A25289 | 21991504 | ISRN Gastroenterol | Prevalence of NAFLD in Healthy and Young Male Individuals. | 2011 | Details |
| A25296 | 21987488 | Hepatology | Ethnicity and nonalcoholic fatty liver disease. | 2012 | Details |
| A25297 | 21987293 | Hepatology | Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis. | 2011 | Details |
| A25306 | 21981787 | Aliment Pharmacol Ther | The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases. | 2011 | Details |
| A25309 | 21971896 | Sao Paulo Med J | Steatosis of indeterminate cause in a pediatric group: is it a primary mitochondrial hepatopathy? | 2011 | Details |
| A25325 | 21954411 | World J Hepatol | Noninvasive predictors for liver fibrosis in patients with nonalcoholic steatohepatitis. | 2011 | Details |
| A25327 | 21953442 | Hepatology | Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease. | 2011 | Details |
| A25330 | 21952989 | Hepatology | "Normal" liver stiffness measure (LSM) values are higher in both lean and obese individuals: a population-based study from a developing country. | 2011 | Details |
| A25332 | 21952702 | Arq Gastroenterol | Analysis of the sustained virological response in patients with chronic hepatitis C and liver steatosis. | 2012 | Details |
| A25333 | 21951922 | Hepatol Res | Efficacy of pitavastatin for the treatment of non-alcoholic steatohepatitis with dyslipidemia: An open-label, pilot study. | 2011 | Details |
| A25334 | 21951869 | Hepatol Res | Clinicopathological features of non-alcoholic fatty liver disease. | 2011 | Details |
| A25335 | 21950746 | J Gastroenterol Hepatol | Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease. | 2011 | Details |
| A25339 | 21948267 | Obes Surg | Nonalcoholic steatohepatitis (NASH) does not increase complications after laparoscopic bariatric surgery. | 2011 | Details |
| A25342 | 21946918 | Mol Med Rep | Nifedipine prevents hepatic fibrosis in a non-alcoholic steatohepatitis model induced by an L-methionine-and choline-deficient diet. | 2011 | Details |
| A25343 | 21946149 | Exp Mol Pathol | Adiponectin reduces connective tissue growth factor in human hepatocytes which is already induced in non-fibrotic non-alcoholic steatohepatitis. | 2011 | Details |
| A25348 | 21940261 | Adv Med Sci | Ultrastructure of liver progenitor/oval cells in children with nonalcoholic steatohepatitis. | 2011 | Details |
| A25362 | 21920102 | S Afr Med J | APRI: a simple bedside marker for advanced fibrosis that can avoid liver biopsy in patients with NAFLD/NASH. | 2011 | Details |
| A25367 | 21913918 | Eur J Clin Invest | Characterization of nonalcoholic fatty liver disease unrelated to the metabolic syndrome. | 2011 | Details |
| A25372 | 21911891 | Ann Hepatol | Plasminogen activator inhibitor type 1 serum levels and 4G/5G gene polymorphism in morbidly obese Hispanic patients with non-alcoholic fatty liver disease. | 2011 | Details |
| A25380 | 21906580 | Am J Pathol | Melanocortin 4 receptor-deficient mice as a novel mouse model of nonalcoholic steatohepatitis. | 2011 | Details |
| A25383 | 21904208 | Eur J Gastroenterol Hepatol | Steatosis degree, measured by morphometry, is linked to other liver lesions and metabolic syndrome components in patients with NAFLD. | 2011 | Details |
| A25390 | 21898479 | Hepatology | Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients. | 2011 | Details |
| A25391 | 21894552 | J Mol Med (Berl) | Genetic variants in candidate genes influencing NAFLD progression. | 2011 | Details |
| A25395 | 21894008 | Dig Dis | Obesity and fatty liver are 'grease' for the machinery of hepatic fibrosis. | 2011 | Details |
| A25397 | 21893273 | Gastroenterol Clin North Am | Nonalcoholic fatty liver disease: pharmacologic and surgical options. | 2011 | Details |
| A25398 | 21892559 | Nutr Hosp | Molecular mechanisms of steatosis in nonalcoholic fatty liver disease. | 2012 | Details |
| A25404 | 21886843 | PLoS One | Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. | 2011 | Details |
| A25408 | 21883454 | J Gastroenterol Hepatol | Transitional features of histologic type of non-alcoholic fatty liver disease in Korean young men. | 2012 | Details |
| A25417 | 21876630 | World J Gastroenterol | Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence. | 2011 | Details |
| A25420 | 21875310 | Crit Rev Clin Lab Sci | Non-alcoholic fatty liver disease. | 2011 | Details |
| A25423 | 21872093 | Prim Care | Care of chronic liver disease. | 2011 | Details |
| A25429 | 21857953 | PLoS One | Increased diacylglycerols characterize hepatic lipid changes in progression of human nonalcoholic fatty liver disease; comparison to a murine model. | 2011 | Details |
| A25430 | 21855538 | Exp Mol Pathol | Elevated systemic monocyte chemoattractrant protein-1 in hepatic steatosis without significant hepatic inflammation. | 2011 | Details |
| A25431 | 21853259 | Environ Health Prev Med | Development of novel rat model for high-fat and high-cholesterol diet-induced steatohepatitis and severe fibrosis progression in SHRSP5/Dmcr. | 2011 | Details |
| A25435 | 21846782 | Gut | Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography. | 2011 | Details |
| A25439 | 21840395 | Biochim Biophys Acta | Genetic modifiers of non-alcoholic fatty liver disease progression. | 2011 | Details |
| A25442 | 21836480 | Am J Surg Pathol | Centrizonal arteries and microvessels in nonalcoholic steatohepatitis. | 2011 | Details |
| A25443 | 21836057 | Am J Physiol Gastrointest Liver Physiol | Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition. | 2011 | Details |
| A25446 | 21830099 | Eur Radiol | Signal profile on Gd-EOB-DTPA-enhanced MR imaging in non-alcoholic steatohepatitis and liver cirrhosis induced in rats: correlation with transporter expression. | 2011 | Details |
| A25453 | 21817060 | Am J Physiol Gastrointest Liver Physiol | Altered lipid metabolism in Hfe-knockout mice promotes severe NAFLD and early fibrosis. | 2011 | Details |
| A25456 | 21813474 | Gut | Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. | 2011 | Details |
| A25457 | 21810560 | Eur J Med Res | The non-invasive (13)C-methionine breath test detects hepatic mitochondrial dysfunction as a marker of disease activity in non-alcoholic steatohepatitis. | 2011 | Details |
| A25462 | 21806828 | J Biomed Sci | Discovery of serum biomarkers of alcoholic fatty liver in a rodent model: C-reactive protein. | 2011 | Details |
| A25476 | 21791204 | Exp Mol Pathol | MMP-9 activity is increased by adiponectin in primary human hepatocytes but even negatively correlates with serum adiponectin in a rodent model of non-alcoholic steatohepatitis. | 2011 | Details |
| A25477 | 21790685 | Aliment Pharmacol Ther | Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease. | 2011 | Details |
| A25478 | 21788761 | J Pediatr Gastroenterol Nutr | Ultrasonographic quantitative estimation of hepatic steatosis in children With NAFLD. | 2011 | Details |
| A25484 | 21778625 | Nihon Ronen Igakkai Zasshi | [Organs related to glucose metabolism and aging in animal models]. | 2011 | Details |
| A25485 | 21777557 | J Hepatol | The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver. | 2011 | Details |
| A25489 | 21773052 | J Lipids | Nonalcoholic Fatty liver disease: focus on lipoprotein and lipid deregulation. | 2011 | Details |
| A25490 | 21773018 | J Nutr Metab | Evaluation of Biomarkers of NAFLD in a Cohort of Morbidly Obese Patients. | 2011 | Details |
| A25507 | 21756849 | J Hepatol | The SOD2 C47T polymorphism influences NAFLD fibrosis severity: evidence from case-control and intra-familial allele association studies. | 2011 | Details |
| A25508 | 21742296 | Clin Res Hepatol Gastroenterol | Liver fibrogenesis and metabolic factors. | 2011 | Details |
| A25515 | 21750883 | J Gastroenterol | Platelet count for predicting fibrosis in nonalcoholic fatty liver disease. | 2011 | Details |
| A25518 | 21748770 | Hepatology | Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: a 12-month randomized, prospective, open- label trial. | 2011 | Details |
| A25520 | 21748765 | Hepatology | Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial. | 2011 | Details |
| A25523 | 21745307 | Liver Int | PNPLA3 polymorphism influences liver fibrosis in unselected patients with type 2 diabetes. | 2011 | Details |